Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $13.8850 (0.33%) ($13.8850 - $13.8850) on Thu. Aug. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.96% (three month average) | RSI | 66 | Latest Price | $13.8850(0.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2.8% a day on average for past five trading days. | Weekly Trend | ATRA advances 3.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) ARKG(46%) IBB(46%) ARKK(45%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.48% in a week (0% probabilities). VIXM(-37%) VXX(-28%) IGOV(-15%) UNG(-13%) TLT(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.48% (StdDev 2.96%) | Hourly BBV | 0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $13.47(3.08%) | 10 Day Moving Average | $12.97(7.05%) | 20 Day Moving Average | $12.81(8.39%) | To recent high | -16.2% | To recent low | 15.7% | Market Cap | $1.032b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |